During the past decade, Horizon Research Group, LLC conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Horizon Research Group, LLC" #1 sponsor was "Apellis Pharmaceuticals, Inc." with 1 trials, followed by "Ardelyx" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Regulus Therapeutics Inc." with 1 trials sponsored and "Vertex Pharmaceuticals Incorporated" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Horizon Research Group, LLC" are "ADPKD" (1 trials), "Autosomal Dominant Polycystic Kidney Disease" (1 trials), "C3 Glomerulonephritis" (1 trials), "Dense Deposit Disease" (1 trials) and "Hyperkalemia" (1 trials). Many other conditions were trialed in "Horizon Research Group, LLC" in a lesser frequency.

Most popular intervention types in "Horizon Research Group, LLC" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "APL-2" (1 trials), "BI 690517" (1 trials), "Empagliflozin" (1 trials) and "Placebo to BI 690517" (1 trials). Other intervention names were less common.

The vast majority of trials in "Horizon Research Group, LLC" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Horizon Research Group, LLC". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Horizon Research Group, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Horizon Research Group, LLC, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".